Back to All Events

2026 Cancer Updates GU and Lung, Philadelphia, PA

  • TBD Philadelphia, PA (map)
Register For Free Today
Become An Exhibitor

In-Person Access Only | 1.75 CE/CME Credits

All programs remain free. Registrations will require a credit card as a cancellation hold. A fee of $25 will only be incurred in the event of a no-show or cancellation within 5 days without written confirmation to the Total Health Program Team.

The Cancer Updates GU and Lung Conference will consist of educational activities designed to meet the needs of medical oncologists, pharmacists, advanced practitioners, and nurses involved in the treatment of GU and lung cancers. Each agenda is comprised of presentations that will break down the most clinically relevant information applicable to community care. This dinner program will be hosted as an in-person event only.

 

Conference Agenda
September 24, 2026

5:15 PM
Networking and Cocktails

5:30 PM
Welcome and Opening Remarks

5:35 PM
Updates in GU Cancer

6:05 PM
GU Cancer Panel Discussion

6:25 PM
Break and Exhibits

6:40 PM
Non CME Session

7:25 PM
2025 Practice Changes in Small Cell Lung Cancer

7:55 PM
Lung Cancer Panel Discussion

8:15 PM
Adjourn

Agenda Subject To Change. All times are CST.

 
    • Review recent clinical advances in the treatment of GU cancers and lung malignancies, with a focus on the most relevant data from recent studies and clinical trials.

    • Evaluate the role of emerging therapies in GU cancers and lung malignancies, treatment, including new medications, targeted therapies, and immunotherapies.

    • Apply evidence-based strategies to improve patient outcomes in community oncology settings, focusing on the integration of new treatment approaches.

    • Assess and manage side effects and toxicities associated with current and emerging therapies in GU cancers and lung malignancies, patients.

    • Discuss multidisciplinary care approaches that enhance collaboration between oncologists, pharmacists, nurses, and advanced practitioners in treating GU cancers and lung malignancies.

  • In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Nurses (ANCC) Credit Designation

    Amedco LLC designates this activity for a maximum of 1.75 ANCC contact hours.

    Physicians (ACCME) Credit Designation

    Amedco LLC designates this live activity for a maximum of 1.75 AMA PRA Category 1 Credits TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Pharmacists and Pharmacy Technicians (ACPE) Credit Designation

    Amedco LLC designates this activity for a maximum of 1.75 knowledge-based CPE contact hours.

    NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of your participation in the activity to meet the deadline for submission to CPE Monitor.

    • Free registration for all healthcare providers

    • Expert sessions that present the most clinically relevant data, research, and clinical strategies

    • Real-time discussion and debate

    • Networking with peers, colleagues, and medical professionals

    • Access to the latest industry information and resources

 
Follow for Updates
Previous
Previous
September 24

2026 Cancer Updates Lung and Breast, Dallas, TX

Next
Next
October 1

2026 Cancer Updates GI and Breast, Boston, MA